NanoViricides
NNVC
#10368
Rank
S$41.05 M
Marketcap
S$1.79
Share price
3.05%
Change (1 day)
0.01%
Change (1 year)

NanoViricides (NNVC) - Cash on Hand

Cash on Hand as of September 2025 : S$1.45 Million

According to NanoViricides's latest financial reports the company has S$1.45 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

NanoViricides - Cash on Hand chart (from 2006 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-06-30S$1.98 M-69.53%
2024-06-30S$6.49 M-41.02%
2023-06-30S$11.01 M-43.65%
2022-06-30S$19.55 M-29.12%
2021-06-30S$27.58 M44.41%
2020-06-30S$19.1 M453.11%
2019-06-30S$3.45 M-64.21%
2018-06-30S$9.65 M-53.57%
2017-06-30S$20.78 M-36.14%
2016-06-30S$32.54 M-23.23%
2015-06-30S$42.39 M-7.32%
2014-06-30S$45.75 M158.93%
2013-06-30S$17.66 M-2.32%
2012-06-30S$18.08 M59.79%
2011-06-30S$11.31 M17.2%
2010-06-30S$9.65 M295.78%
2009-06-30S$2.44 M119.66%
2008-06-30S$1.11 M-25.16%
2007-06-30S$1.48 M-62.8%
2006-06-30S$3.99 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Gilead Sciences
GILD
S$9.88 B 678,849.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$7.37 B 506,424.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$13.56 B 931,401.01%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$5.89 B 404,947.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
S$1.02 B 70,107.42%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
S$0.30 B 21,077.75%๐Ÿ‡บ๐Ÿ‡ธ USA